发明名称 NOVEL HSP90-TARGETED ANTI-CANCER CHIMERIC PEPTIDE
摘要 <p>Disclosed is a substance which is not accumulated stably in cells, does not cause the dysfunction of normal cells, and so on, and therefore can be used as an anti-cancer agent or a DDS having no adverse side effect.  It is found that Hsp90 alone cannot exhibit a chaperon function that can assist the refolding of a protein such as surviving, but can exhibit the function when Hop (which is one of partner proteins of Hsp90) binds to Hsp90.  Thus, specifically disclosed is a chimeric peptide comprising an Hsp90 TPR domain binding peptide and a cell-penetrating peptide.</p>
申请公布号 WO2010055929(A1) 申请公布日期 2010.05.20
申请号 WO2009JP69405 申请日期 2009.11.13
申请人 KYOTO UNIVERSITY;KAWAKAMI KOJI;KOHNO MASAYUKI;HORIBE TOMOHISA 发明人 KAWAKAMI KOJI;KOHNO MASAYUKI;HORIBE TOMOHISA
分类号 C12N15/09;A61K9/127;A61K38/00;A61K45/00;A61K47/48;A61P35/00;A61P43/00;C07K7/08;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;G01N33/15;G01N33/50 主分类号 C12N15/09
代理机构 代理人
主权项
地址